Patient Journey Scope Estimator
60% of drug launches miss year-1 forecasts. Most never recover.

Know what your patients are going through.
Before launch.

Most launches are built on assumptions. Survey data, HCP panels, synthetic personas. None of them tell you what patients actually experience between symptom onset and your drug. This estimator shows you the patient intelligence scope your launch needs, for your exact disease areas and target markets.

Calculate my data scope →
01 — Disease areas
Which diseases are you targeting?
We structure patient conversations across 20+ diseases. The more specific you are, the sharper your scope.
02 — Target markets
Which countries are you targeting?
Every market is different. Your scope reflects your specific markets, not industry averages.
Select countries
03 — Launch stage
What stage is your drug launch?
Select the current phase of your programme.
Select stage
Discovery and development
Preclinical research
Clinical research
Regulatory review / submission
Post-market safety monitoring
Other
Mapping patient journeys…
Your estimate
Patients in cohort
Data points
mama health — Cohort Journey Explorer
What’s included
Diagnosis journey

Know where patients get lost before they ever reach your drug. Time-to-diagnosis, misdiagnosis rates, and the triggers that finally push them toward care.

Referral pathways

Identify which specialists are actually driving diagnosis in your market. Know whether your field team is calling on the right doctors before launch day.

Treatment journey

Understand why patients switch, delay, or stop. Line of therapy, adherence patterns, and discontinuation reasons told in their own words.

Daily life impacts

The functional and emotional burden patients carry every day. What they actually need from a treatment, beyond what clinical trials measure.

Unmet needs

The gaps your launch strategy doesn’t know it has yet. What patients say is missing from their care, their support, and their relationship with the system.

This is an estimated investment based on your selected markets and disease areas. Exact scope and pricing depend on your specific launch timeline and objectives. We’ll be in touch to walk you through the details — or if you’d prefer not to wait, book a call directly →
Disease areas
Target markets
Built for life science teams

Your launch team is making decisions about patients they have never heard from.

Every function has a different view of the patient. mama health gives commercial, medical, and marketing teams one shared source of real patient intelligence, so launch decisions stop being built on whoever had the loudest opinion in the room.

For Commercial Teams

Optimize launches on real patient behavior.

Understand why patients switch, delay, or drop off — not just that they do. Primary patient conversations surface the behavioral reasons behind every market signal, giving your commercial team the context to act, not just react.

For Medical Affairs

Evidence the experience trial data doesn’t capture.

RWE pipelines tell you what was prescribed and billed. They don’t tell you why patients stopped, or what they wished their physician had asked. mama health structures all of it — ready for evidence dossiers and advisory boards.

For Marketing Teams

Test messaging on the people it’s for.

Brand teams test concepts on synthetic audiences and HCP panels — and find out months later that patients heard something different. Close the loop in days. Ranked benchmarks against real cohorts.

Behind the dashboard

How patient stories become signal.

You don’t manage recruitment, interviews, or structuring. We do. You get a live dashboard, refreshed weekly as new patients come in.

Step 01

Sourced.

patients recruited and condition-verified at intake.

Step 02

Heard.

30–60 min AI-moderated interviews, clinician-reviewed protocol.

Step 03

Structured.

anonymised, GDPR & HIPAA aligned, structured for your insights team.

Step 04

Delivered.

refreshed weekly as new patients come in.

50,000+ patients15+ marketsGDPR & HIPAA alignedMedically supervised